James Lymp

10.2k total citations · 4 hit papers
55 papers, 7.5k citations indexed

About

James Lymp is a scholar working on Oncology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, James Lymp has authored 55 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Epidemiology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in James Lymp's work include CAR-T cell therapy research (13 papers), Liver Disease Diagnosis and Treatment (8 papers) and Lymphoma Diagnosis and Treatment (7 papers). James Lymp is often cited by papers focused on CAR-T cell therapy research (13 papers), Liver Disease Diagnosis and Treatment (8 papers) and Lymphoma Diagnosis and Treatment (7 papers). James Lymp collaborates with scholars based in United States, United Kingdom and Germany. James Lymp's co-authors include Paul Angulo, Keith D. Lindor, Leon A. Adams, Schuyler O. Sanderson, Ariel E. Feldstein, Raynell Clark, Robert A. Kyle, Jerry A. Katzmann, Roshini S. Abraham and Sandra C. Bryant and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

James Lymp

55 papers receiving 7.3k citations

Hit Papers

The Natural History of Nonalcoholic Fatty Liver Disease: ... 2002 2026 2010 2018 2005 2004 2002 2020 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
    2005 2.2k citations James Lymp, Keith D. Lindor et al. profile →
  2. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial
    2004 545 citations Keith D. Lindor, Kris V. Kowdley et al. Hepatology profile →
  3. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
    2002 478 citations James Lymp et al. profile →
  4. Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure
    2020 227 citations James Lymp et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Lymp United States 33 3.7k 1.8k 1.5k 1.5k 1.2k 55 7.5k
Qilong Yi Canada 54 2.2k 0.6× 1.2k 0.6× 1.2k 0.8× 1.2k 0.8× 1.5k 1.3× 204 10.7k
Daniel Q. Huang Singapore 35 4.8k 1.3× 1.3k 0.7× 2.8k 1.9× 1.0k 0.7× 284 0.2× 180 7.1k
Robert J. Wong United States 50 6.1k 1.6× 1.5k 0.8× 4.8k 3.3× 1.1k 0.7× 496 0.4× 323 10.4k
Sydney Tang Hong Kong 51 974 0.3× 676 0.4× 480 0.3× 2.0k 1.4× 944 0.8× 314 9.4k
Steven J. Chadban Australia 62 1.3k 0.4× 984 0.5× 418 0.3× 1.5k 1.1× 1.6k 1.4× 283 12.8k
Chul Woo Yang South Korea 47 1.1k 0.3× 597 0.3× 425 0.3× 2.0k 1.4× 1.4k 1.2× 526 9.8k
Parambir S. Dulai United States 40 4.7k 1.3× 790 0.4× 1.2k 0.8× 846 0.6× 288 0.2× 254 8.0k
Dirk Kuypers Belgium 69 1.9k 0.5× 439 0.2× 853 0.6× 1.8k 1.3× 2.0k 1.7× 352 16.0k
Bart Maes Belgium 53 1.1k 0.3× 766 0.4× 458 0.3× 694 0.5× 1.1k 1.0× 215 8.9k
Norberto Perico Italy 65 853 0.2× 1.1k 0.6× 649 0.4× 2.6k 1.8× 1.5k 1.3× 292 14.2k

Countries citing papers authored by James Lymp

Since Specialization
Citations

This map shows the geographic impact of James Lymp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Lymp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Lymp more than expected).

Fields of papers citing papers by James Lymp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Lymp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Lymp. The network helps show where James Lymp may publish in the future.

Co-authorship network of co-authors of James Lymp

This figure shows the co-authorship network connecting the top 25 collaborators of James Lymp. A scholar is included among the top collaborators of James Lymp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Lymp. James Lymp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
OGASAWARA, K., James Lymp, Timothy R. Mack, et al.. (2022). In Vivo Cellular Expansion of Lisocabtagene Maraleucel and Association With Efficacy and Safety in Relapsed/Refractory Large B‐Cell Lymphoma. Clinical Pharmacology & Therapeutics. 112(1). 81–89. 14 indexed citations
2.
3.
4.
Brown, Jennifer R., Susan O’Brien, Herbert Eradat, et al.. (2015). Obinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trial. Blood. 125(18). 2779–2785. 57 indexed citations
5.
Conrad, C., James Lymp, Valeria Thompson, et al.. (2014). Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial. Journal of Cystic Fibrosis. 14(2). 219–227. 80 indexed citations
6.
Anstead, Michael, Sonya L. Heltshe, Umer Khan, et al.. (2012). Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial. Journal of Cystic Fibrosis. 12(2). 147–153. 26 indexed citations
7.
Bennett, Antonia V., Donald L. Patrick, James Lymp, Todd C. Edwards, & Christopher H. Goss. (2010). Comparison of 7-day and repeated 24-hour recall of symptoms of cystic fibrosis. Journal of Cystic Fibrosis. 9(6). 419–424. 21 indexed citations
8.
Rhew, Isaac C., Kate Simpson, Melissa Tracy, et al.. (2010). Criterion validity of the Short Mood and Feelings Questionnaire and one- and two-item depression screens in young adolescents. Child and Adolescent Psychiatry and Mental Health. 4(1). 8–8. 127 indexed citations
9.
Chartier, Maggie, Ann Vander Stoep, Elizabeth McCauley, et al.. (2008). Passive Versus Active Parental Permission: Implications for the Ability of School‐Based Depression Screening to Reach Youth at Risk*. Journal of School Health. 78(3). 157–164. 75 indexed citations
10.
Delaunoit, Thierry, Paul J. Limburg, Richard M. Goldberg, James Lymp, & Edward V. Loftus. (2006). Colorectal Cancer Prognosis Among Patients With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. 4(3). 335–342. 113 indexed citations
11.
Suzuki, Ayako, et al.. (2006). Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis. Liver International. 26(10). 1209–1216. 61 indexed citations
12.
Suzuki, Ayako, et al.. (2006). Clinical Predictors for Hepatocellular Carcinoma in Patients With Primary Biliary Cirrhosis. Clinical Gastroenterology and Hepatology. 5(2). 259–264. 40 indexed citations
13.
Doerr, Clinton H., et al.. (2005). Hypercapnic Acidosis Impairs Plasma Membrane Wound Resealing in Ventilator-injured Lungs. American Journal of Respiratory and Critical Care Medicine. 171(12). 1371–1377. 94 indexed citations
14.
Ryu, Jay H., et al.. (2005). Familial Idiopathic Pulmonary Fibrosis. CHEST Journal. 127(6). 2034–2041. 94 indexed citations
15.
Levy, Cynthia, James Lymp, Paul Angulo, et al.. (2005). The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing Cholangitis. Digestive Diseases and Sciences. 50(9). 1734–1740. 226 indexed citations
16.
Gajić, Ognjen, Saqib I. Dara, José L. Méndez, et al.. (2004). Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation*. Critical Care Medicine. 32(9). 1817–1824. 492 indexed citations
17.
Morales, Ian J., Steve G. Peters, Mark T. Keegan, et al.. (2004). The Hospital Mortality of Patients Admitted to the ICU on Weekends. CHEST Journal. 126(4). 1292–1298. 123 indexed citations
18.
Lindor, Keith D., Kris V. Kowdley, Jenny Heathcote, et al.. (2004). Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial. Hepatology. 39(3). 770–778. 545 indexed citations breakdown →
19.
McLeod, Thomas G., Jon O. Ebbert, & James Lymp. (2003). Survey Assessment of Personal Digital Assistant Use among Trainees and Attending Physicians. Journal of the American Medical Informatics Association. 10(6). 605–607. 76 indexed citations
20.
Burgess, Jefferey L., et al.. (2001). Hazardous materials events: Evaluation of transport to health care facility and evacuation decisions. The American Journal of Emergency Medicine. 19(2). 99–105. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qilong Yi Breakdown of academic impact, for papers by Daniel Q. Huang Breakdown of academic impact, for papers by Robert J. Wong Breakdown of academic impact, for papers by Sydney Tang Breakdown of academic impact, for papers by Steven J. Chadban Breakdown of academic impact, for papers by Chul Woo Yang Breakdown of academic impact, for papers by Parambir S. Dulai Breakdown of academic impact, for papers by Dirk Kuypers Breakdown of academic impact, for papers by Bart Maes Breakdown of academic impact, for papers by Norberto Perico
Rankless by CCL
2026